These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38383342)

  • 21. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15.
    Wang Y; Jiang F; Xiong Y; Cheng X; Qiu Z; Song R
    Life Sci; 2020 Mar; 244():116936. PubMed ID: 31610194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
    Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
    J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
    He YC; Bi YG; Jiang L
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8740-8746. PubMed ID: 32964962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription.
    Luo XJ; He MM; Liu J; Zheng JB; Wu QN; Chen YX; Meng Q; Luo KJ; Chen DL; Xu RH; Zeng ZL; Liu ZX; Luo HY
    Exp Mol Med; 2022 Jun; 54(6):834-847. PubMed ID: 35760875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Non-coding RNA LOXL1-AS1 Facilitates Colorectal Cancer Progression via Regulating miR-1224-5p/miR-761/HK2 Axis.
    Guo T; Peng S; Liu D; Li Y
    Biochem Genet; 2022 Dec; 60(6):2416-2433. PubMed ID: 35441953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1.
    Liu X; Wang H; Tao GL; Chu TB; Wang YX; Liu L
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11006-11015. PubMed ID: 33215415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated lncRNA Cyclin-dependent kinase inhibitor 2B antisense RNA 1 induces the proliferation and migration of colorectal cancer by miR-378b/CAPRIN2 axis.
    Zheng Y; Zeng J; Xia H; Wang X; Chen H; Huang L; Zeng C
    Bioengineered; 2021 Dec; 12(1):5476-5490. PubMed ID: 34511033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propofol suppresses hypoxia-induced esophageal cancer cell migration, invasion, and EMT through regulating lncRNA TMPO-AS1/miR-498 axis.
    Gao M; Guo R; Lu X; Xu G; Luo S
    Thorac Cancer; 2020 Sep; 11(9):2398-2405. PubMed ID: 32643321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
    Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z
    Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894
    [No Abstract]   [Full Text] [Related]  

  • 30. lncRNA MCM3AP-AS1 inhibits the progression of colorectal cancer via the miR-19a-3p/FOXF2 axis.
    Dai W; Zeng W; Lee D
    J Gene Med; 2021 Mar; 23(3):e3306. PubMed ID: 33450091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis.
    Lei R; Feng L; Hong D
    Cancer Biomark; 2020; 27(4):433-443. PubMed ID: 31929141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA IGFL2-AS1 as a ceRNA Promotes HCT116 Cell Malignant Proliferation via the miR-433-3p/PAK4 Axis.
    Liu S; Wang X; Zhang J; Liu Y; Li B
    Turk J Gastroenterol; 2023 May; 34(5):497-507. PubMed ID: 36620931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethoxy-erianin phosphate inhibits angiogenesis in colorectal cancer by regulating the TMPO-AS1/miR-126-3p/PIK3R2 axis and inactivating the PI3k/AKT signaling pathway.
    Liu S; Teng F; Lu Y; Zhu Y; Liang X; Wu F; Liu J; Zhou W; Su C; Cao Y
    BMC Cancer; 2024 Oct; 24(1):1275. PubMed ID: 39402462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA TMPO-AS1 promotes cell proliferation, migration, invasion and epithelial-to-mesenchymal transition in gallbladder carcinoma by regulating the microRNA-1179/E2F2 axis.
    Sui Z; Sui X
    Oncol Lett; 2021 Dec; 22(6):855. PubMed ID: 34777589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CERS6-AS1 contributes to the malignant phenotypes of colorectal cancer cells by interacting with miR-15b-5p to regulate SPTBN2.
    Zhao SY; Wang Z; Wu XB; Zhang S; Chen Q; Wang DD; Tan QF
    Kaohsiung J Med Sci; 2022 May; 38(5):403-414. PubMed ID: 35146902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
    Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
    J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA COL4A2-AS1 facilitates cell proliferation and glycolysis of colorectal cancer cells via miR-20b-5p/hypoxia inducible factor 1 alpha subunit axis.
    Yu Z; Wang Y; Deng J; Liu D; Zhang L; Shao H; Wang Z; Zhu W; Zhao C; Ke Q
    Bioengineered; 2021 Dec; 12(1):6251-6263. PubMed ID: 34477476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
    Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
    Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis.
    Zhang Z; Yang W; Li N; Chen X; Ma F; Yang J; Zhang Y; Chai X; Zhang B; Hou X; Luo S; Hua Y
    Carcinogenesis; 2021 Feb; 42(2):263-271. PubMed ID: 32860508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
    Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
    Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.